Amoxicillin / Clavulanate Potassium 875 mg / 125 mg Tablets, 20 count — Hikma

NDC: 0143-9249-20

Amoxicillin / Clavulanate Potassium 875 mg / 125 mg Tablets, 20 count — Hikma

Active ingredients	Amoxicillin 875 mg (as trihydrate) and clavulanic acid 125 mg (as potassium salt) per tablet
Dosage form	Film-coated, scored oral tablet
Route	Oral
Size	20 tablets per bottle
Manufacturer	Hikma
NDC	0143-9249-20

Indications and Usage

Treatment of beta-lactamase-producing bacterial infections, including lower respiratory tract infections, acute bacterial otitis media, sinusitis, skin and skin-structure infections, and urinary tract infections.

Dosage and Administration

Adults and pediatric patients weighing 40 kg or more: one 875 mg tablet every 12 hours (dosed on the amoxicillin component). Take at the start of a meal to reduce gastrointestinal upset.

Warnings and Precautions

• Serious hypersensitivity and anaphylactic reactions
• Severe cutaneous adverse reactions; discontinue if rash progresses
• Clostridioides difficile-associated diarrhea
• Hepatic dysfunction and cholestatic jaundice; avoid use in mononucleosis

Contraindications

History of a serious hypersensitivity reaction to a penicillin or cephalosporin, or prior cholestatic jaundice or hepatic dysfunction associated with amoxicillin/clavulanate.

Adverse Reactions

Most commonly diarrhea or loose stools, nausea, and skin rash or urticaria.

Storage and Handling

Store at 20°C to 25°C (68°F to 77°F) in a tight container.

How Supplied

Supplied as 20 scored, capsule-shaped tablets in a bottle.

Professional use only. Clinical information summarized from FDA-approved prescribing information (Structured Product Labeling); refer to the full prescribing information via DailyMed for complete details.